1|0|Public
5000|$|<b>Ifoxetine</b> (CGP-15,210-G) is a {{selective}} serotonin reuptake inhibitor (SSRI) which was investigated as an antidepressant in the 1980s but was never marketed. <b>Ifoxetine</b> selectively blocks the reuptake of serotonin {{in the brain}} supposedly without affecting it in the [...] Supporting this claim, <b>ifoxetine</b> {{was found to be}} efficacious in clinical trials and was very well tolerated, producing almost no physical side effects or other complaints of significant concern.|$|E

